155 related articles for article (PubMed ID: 25492570)
1. Sevoflurane promotes the expansion of glioma stem cells through activation of hypoxia-inducible factors in vitro.
Shi QY; Zhang SJ; Liu L; Chen QS; Yu LN; Zhang FJ; Yan M
Br J Anaesth; 2015 May; 114(5):825-30. PubMed ID: 25492570
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha.
Soeda A; Park M; Lee D; Mintz A; Androutsellis-Theotokis A; McKay RD; Engh J; Iwama T; Kunisada T; Kassam AB; Pollack IF; Park DM
Oncogene; 2009 Nov; 28(45):3949-59. PubMed ID: 19718046
[TBL] [Abstract][Full Text] [Related]
3. Stem cell-like human endothelial progenitors show enhanced colony-forming capacity after brief sevoflurane exposure: preconditioning of angiogenic cells by volatile anesthetics.
Lucchinetti E; Zeisberger SM; Baruscotti I; Wacker J; Feng J; Zaugg K; Dubey R; Zisch AH; Zaugg M
Anesth Analg; 2009 Oct; 109(4):1117-26. PubMed ID: 19762739
[TBL] [Abstract][Full Text] [Related]
4. Cardiac glycosides suppress the maintenance of stemness and malignancy via inhibiting HIF-1α in human glioma stem cells.
Lee DH; Cheul Oh S; Giles AJ; Jung J; Gilbert MR; Park DM
Oncotarget; 2017 Jun; 8(25):40233-40245. PubMed ID: 28410215
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of miR-210 decreases hypoxic glioma stem cells stemness and radioresistance.
Yang W; Wei J; Guo T; Shen Y; Liu F
Exp Cell Res; 2014 Aug; 326(1):22-35. PubMed ID: 24930954
[TBL] [Abstract][Full Text] [Related]
6. Cytoprotective effects of the volatile anesthetic sevoflurane are highly dependent on timing and duration of sevoflurane conditioning: findings from a human, in-vitro hypoxia model.
Zitta K; Meybohm P; Bein B; Ohnesorge H; Steinfath M; Scholz J; Albrecht M
Eur J Pharmacol; 2010 Oct; 645(1-3):39-46. PubMed ID: 20655305
[TBL] [Abstract][Full Text] [Related]
7. The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling.
Ping YF; Yao XH; Jiang JY; Zhao LT; Yu SC; Jiang T; Lin MC; Chen JH; Wang B; Zhang R; Cui YH; Qian C; Wang Jm; Bian XW
J Pathol; 2011 Jul; 224(3):344-54. PubMed ID: 21618540
[TBL] [Abstract][Full Text] [Related]
8. RNA interference targeting hypoxia-inducible factor 1α via a novel multifunctional surfactant attenuates glioma growth in an intracranial mouse model.
Gillespie DL; Aguirre MT; Ravichandran S; Leishman LL; Berrondo C; Gamboa JT; Wang L; King R; Wang X; Tan M; Malamas A; Lu ZR; Jensen RL
J Neurosurg; 2015 Feb; 122(2):331-41. PubMed ID: 25423275
[TBL] [Abstract][Full Text] [Related]
9. Sevoflurane attenuate hypoxia-induced VEGF level in tongue squamous cell carcinoma cell by upregulating the DNA methylation states of the promoter region.
Lu Y; Wang J; Yan J; Yang Y; Sun Y; Huang Y; Hu R; Zhang Y; Jiang H
Biomed Pharmacother; 2015 Apr; 71():139-45. PubMed ID: 25960229
[TBL] [Abstract][Full Text] [Related]
10. Preconditioning of mesenchymal stem cells by sevoflurane to improve their therapeutic potential.
Sun X; Fang B; Zhao X; Zhang G; Ma H
PLoS One; 2014; 9(3):e90667. PubMed ID: 24599264
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of ZNF217 in glioblastoma contributes to the maintenance of glioma stem cells regulated by hypoxia-inducible factors.
Mao XG; Yan M; Xue XY; Zhang X; Ren HG; Guo G; Wang P; Zhang W; Huo JL
Lab Invest; 2011 Jul; 91(7):1068-78. PubMed ID: 21483406
[TBL] [Abstract][Full Text] [Related]
12. Isoflurane inhibits occludin expression via up-regulation of hypoxia-inducible factor 1α.
Zhao J; Hao J; Fei X; Wang X; Hou Y; Deng C
Brain Res; 2014 May; 1562():1-10. PubMed ID: 24661914
[TBL] [Abstract][Full Text] [Related]
13. Inhalational Anesthetics Inhibit Neuroglioma Cell Proliferation and Migration via miR-138, -210 and -335.
Ishikawa M; Iwasaki M; Zhao H; Saito J; Hu C; Sun Q; Sakamoto A; Ma D
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919449
[TBL] [Abstract][Full Text] [Related]
14. Sevoflurane inhibits the malignant potential of head and neck squamous cell carcinoma via activating the hypoxia‑inducible factor-1α signaling pathway in vitro.
Yang Y; Hu R; Yan J; Chen Z; Lu Y; Jiang J; Jiang H
Int J Mol Med; 2018 Feb; 41(2):995-1002. PubMed ID: 29207062
[TBL] [Abstract][Full Text] [Related]
15. Isoflurane, a commonly used volatile anesthetic, enhances renal cancer growth and malignant potential via the hypoxia-inducible factor cellular signaling pathway in vitro.
Benzonana LL; Perry NJ; Watts HR; Yang B; Perry IA; Coombes C; Takata M; Ma D
Anesthesiology; 2013 Sep; 119(3):593-605. PubMed ID: 23774231
[TBL] [Abstract][Full Text] [Related]
16. HIF1α regulates single differentiated glioma cell dedifferentiation to stem-like cell phenotypes with high tumorigenic potential under hypoxia.
Wang P; Lan C; Xiong S; Zhao X; Shan Y; Hu R; Wan W; Yu S; Liao B; Li G; Wang J; Zou D; Chen B; Feng H; Wu N
Oncotarget; 2017 Apr; 8(17):28074-28092. PubMed ID: 28427209
[TBL] [Abstract][Full Text] [Related]
17. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
Blancher C; Moore JW; Robertson N; Harris AL
Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
[TBL] [Abstract][Full Text] [Related]
18. Sevoflurane postconditioning involves an up-regulation of HIF-1α and HO-1 expression via PI3K/Akt pathway in a rat model of focal cerebral ischemia.
Ye Z; Guo Q; Xia P; Wang N; Wang E; Yuan Y
Brain Res; 2012 Jun; 1463():63-74. PubMed ID: 22580326
[TBL] [Abstract][Full Text] [Related]
19. Secretion-mediated STAT3 activation promotes self-renewal of glioma stem-like cells during hypoxia.
Almiron Bonnin DA; Havrda MC; Lee MC; Liu H; Zhang Z; Nguyen LN; Harrington LX; Hassanpour S; Cheng C; Israel MA
Oncogene; 2018 Feb; 37(8):1107-1118. PubMed ID: 29155422
[TBL] [Abstract][Full Text] [Related]
20. Sevoflurane Modulates AKT Isoforms in Triple Negative Breast Cancer Cells. An Experimental Study.
Tiron CE; Patrașcanu E; Postu PA; Vacarean Trandafir IC; Tiron A; Grigoras I
Curr Issues Mol Biol; 2021 Jun; 43(1):264-275. PubMed ID: 34199634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
